The term 'reactive oxygen species' (ROS) includes superoxide, hydrogen peroxide, singlet oxygen, ozone, hypohalous acids and organic peroxides 1 . ROS participate in phenomena that traverse all of biology, and their study has burgeoned for more than a century (TIMELINE). ROS are difficult to distinguish from each other by specific assays and are challenging to quantify. The diversity of their enzymatic sources has only recently become apparent, and tools for the identification of their subcellular localization are only now emerging. Many of their effects can be opposed to one another -for example, they can both promote and prevent cell death, inflammation or ageing.
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Further complicating their study, ROS are not the only class of endogenous small, reactive signalling molecules; other classes include reactive nitrogen species (RNS), such as nitric oxide (NO • ) and NO 2 • ; hydrogen sulphide (H 2 S) or its anion HS − ; and carbon monoxide (CO). These other reactive molecules can have properties that both overlap with and are distinct from those of ROS. Scientists who study ROS and RNS organize separate conferences, but the molecules themselves interact and affect the production and targets of one another [3] [4] [5] . Most medical interventions that target ROS have failed (discussed in REF. 6 ). This can be interpreted to mean that ROS have an unimportant role in pathophysiology; however, it might also be that the interventions tested were not based on an adequate understanding of ROS biochemistry and biology, which is still emerging 7 . Moreover, among immunologists who consider specificity the hallmark of the discipline, some labour under the misconception that ROS are nonspecific, and a few cling to the view that only phagocytes produce ROS and that the only function of ROS is to kill pathogens and host cells.
Thus, it is no surprise that until recently it was rare to find a diagram of signal transduction or a systems biology analysis that took ROS into account. However, in the past few years, many of the obstacles mentioned above have been overcome. Scientists are now aware that ROS routinely arise in most cells from defined sources, that they affect multiple targets in specific ways and that they exert considerable influence over cell function.
In this Review, we describe ROS in terms of their regulation, targets and actions. Because the topic is vast, our approach is illustrative rather than comprehensive. Given the conservation of ROS biology, we draw lessons from diverse fields to lend perspective to the role of ROS in immunology.
ROS homeostasis
Many authors state that 'oxidative stress' occurs when the production of ROS exceeds their catabolism. However, the term stress is an imprecise reference to a restricted range of ROS signalling that runs from adaptive to maladaptive (FIG. 1) and has a major role in cell and organismal biology 1, [8] [9] [10] (FIG. 1) . Thus, oxidative stress is by no means a description of, nor a synonym for, the biology of ROS. (BOX 1) include seven isoforms of NADPH oxidases (NOXs) 10, 11 that are differentially expressed in diverse cells and species the flavoenzyme ERO1 in the endoplasmic reticulum; xanthine oxidase; lipoxygenases; cyclooxygenases; cytochrome P450s; a flavin-dependent demethylase; oxidases for polyamines and amino acids; and nitric oxide synthases. Free copper ions or iron ions that are released from iron-sulphur clusters, haem groups or metal storage proteins can convert O 2 •− and/or H 2 O 2 to OH
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• (REF. 13 ).
Regulation of ROS production. Several checkpoints restrict ROS production by the NOXs to times and locations that are appropriate for cellular functions. NOXs are transmembrane flavocytochrome proteins, the cytosolic domains of which transfer an electron from NADPH to a FAD cofactor. From there, the electron is passed to a haem group, which donates it to O 2 on the extracellular side of the membrane, generating O 2
•−
.One control step in this process is the loading of the apoprotein with the flavin cofactor 14 . In another level of regulation, Ca 2+ signalling, phosphorylation cascades and the activation of small G proteins control the recruitment of accessory proteins from the cytosol to join the flavocytochrome at the membrane, forming the functional NOX complex 8 . NOXs are activated following the activation of receptors by ligands such as insulin, platelet-derived Figure 1 | The broad range of ROS signalling is influenced by ROS production and catabolism, and by cellular adaptation. Restriction of reactive oxygen species (ROS) production to appropriate subcellular locations, times, levels, molecular species and for appropriate durations allows ROS to contribute to homeostasis and physiological cell activation. For example, brief pulses of H 2 O 2 production at the plasma membrane or at the endosomal membrane mediate signalling in response to the engagement of receptors with cytokines, microbial products or antigens (left-hand side). When ROS production escapes these restrictions -for example, when there are high levels or sustained production of hydroxyl radicals -macromolecules are damaged ('oxidative stress'). ROS-mediated damage can often be reversed by repair, replacement, degradation or sequestration of the damaged macromolecules (middle). However, damage that exceeds the capacity of the cell for these responses can lead to cell death (right-hand side). When damage to DNA results in mutagenesis without irreparable double-strand breakage, and when damage to other macromolecules is repaired, the consequence can be malignant transformation rather than death of the cell (right-hand side).
Uncoupling proteins
Proteins in the mitochondrial inner membrane that can divert the proton gradient away from the formation of ATP, resulting in the generation of heat instead.
Xenobiotics
Small chemical compounds that enter an organism unnaturally, such as drugs or pollutants.
growth factor, nerve growth factor, fibroblast growth factor, chemokines that bind G protein-coupled receptors, tumour necrosis factor (TNF), granulocytemacrophage colony-stimulating factor (GM-CSF), angio tensin, sphingosine-1-phosphate, lysophospholipids, complement component 5a (C5a) and leukotriene B4 (LTB4), as well as by cell adhesion and by phagocytosis 1, 8 . The mechanisms linking receptor interaction to NOX activation are an important research area in immune signalling.
ROS production by mitochondria is regulated by diverse factors, including RNS, mammalian target of rapamycin (mTOR), p53, SHC-transforming protein 1 (SHC1), reactive oxygen species modulator 1 (ROMO1), B cell lymphoma 2 (BCL-2) family members 8 and uncoupling proteins 15 . Another factor that promotes mitochondrial ROS generation is hypoxia (discussed below).
Nitric oxide synthases (NOS) can produce ROS when concentrations of their cofactor tetrahydrobiopterin or their cosubstrate l-arginine are limiting. For example, following l-arginine depletion by l-arginase, NOS donate some of their NADPH-derived electrons to O 2 rather than passing all the electrons to the guanidino nitrogens of arginine, generating both O 2
•− and NO • . These species react with each other to produce peroxynitrite (OONO − ), which decomposes to generate the strong oxidants OH
• and NO 2
• (REF. 16 ),
and can oxidize redox-sensitive cysteines 10 3 -fold faster than peroxide 17 . Transcriptional networks control proteins that sense and regulate the uptake and the storage of redox-active metal ions 13 . In addition, other mechanisms that affect the intracellular levels of ROS include the export of xenobiotics that generate ROS 13 and the export of ROS themselves into neighbouring cells through connexin channels 18 .
Catabolism of ROS.
Until recently, the antioxidant systems of a cell were thought to be superoxide dismutases, catalases and the enzymes of the glutathione redox cycle, which couples the reduction of peroxide to the oxidation and the regeneration of reduced glutathione. Many additional physiologically important ROS-regulating enzymes are now recognized, among them thioredoxins, thioredoxin reductases 19 , peroxiredoxins (which also function as peroxynitrite reductases) and methionine sulphoxide reductases 8, 20, 21 . Moreover, recent studies have increased our understanding of glutathione homeostasis. For example, the level of reduced glutathione is preserved in yeast not only through the action of glutathione reductase, but also through the actions of thioredoxin reductase and glutaredoxin, and the export of oxidized glutathione into the vacuole 22 . Pyruvate kinase, an enzyme involved in glycolysis and gluconeogenesis, is crucial in the negative feedback regulation of ROS. When cells metabolize glucose, ROS inhibit pyruvate kinase by oxidizing Cys358. The resulting inhibition of glycolysis directs carbon flux into the pentose phosphate pathway. This increases the production of NADPH and sustains the reduction of oxidized glutathione and thioredoxin, returning ROS to homeostatic levels 23 . In addition, many small molecules that react with ROS non-enzymatically can be recycled or replenished, giving them a ROS-buffering capacity. These include ascorbate and the α-ketoacids of central carbon metabolism, such as pyruvate, α-ketoglutarate and oxaloacetate 24 IFNγ is defined as a principal inducer of ROS production and antimicrobial function in humans 147 A subunit of the superoxide-producing NADPH oxidase enzyme discovered in 1978 is cloned on the basis of its being mutated in patients with CGD. This is the first enzyme identified the function of which seems to be the de novo generation of ROS, as opposed to making ROS as a by-product or turning one ROS into another 148 Antibiotics with diverse primary targets are found to kill bacteria partly by inducing them to produce ROS 129 . Thus, a major form of natural host defence against infection and a principal form of medical treatment for infection converge on the generation of ROS
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(pKa). The equilibrium constant for the dissociation of an acid into its conjugate base and hydrogen ion, expressed as the negative logarithm. The lower the pKa of a sulphydryl group, the greater the likelihood that the sulphur will be anionic at ambient pH.
Repair of ROS-mediated damage.
Cells maintain homeostasis despite ROS production not only by catabolizing ROS but also by repairing oxidative injury. For example, ROS can oxidize the sulphurs that hold the iron atoms in the iron-sulphur clusters. As a result, iron atoms are lost. The apoprotein then loses its original function and might have to be re-synthesized for a new iron-sulphur cluster to be attached. DNA oxidation by ROS activates the nucleotide excision repair and base excision repair pathways 13 . Some oxidative damage cannot be repaired, such as the formation of carbonyl groups on amino acid side chains in proteins. This results in cells degrading irreversibly oxidized macromolecules using the proteasome 27 or autophagosomes 28 . Some macromolecules might be so extensively oxidized that they can be neither repaired nor degraded; cells might respond by sequestering these macromolecules with chaperones. Thus, it is not surprising that a genetic screen of viable deletion strains of Saccharomyces cerevisiae for hypersensitivity to ROS identified 456 genes 29 . Many of these genes encoded proteins with additional functions to catabolism of ROS, repair of ROS-dependent damage and the other mechanisms discussed above.
The fact that regulators of ROS are encoded by such a large proportion of the genome and are distributed across so many functional classes reflects the widespread functional effects of ROS. It seems unlikely that evolution selected for fitness by ascribing such a widespread role to molecules that react nonspecifically. We argue below that the biological effects of ROS are in fact highly specific.
Targets of ROS Atomic targets. ROS display a type of specificity that is atomic rather than molecular: ROS react covalently, often reversibly, with only certain atomic elements in macromolecules, and with only a subset of those atoms 30 (FIG. 2) . Therefore, ROS only seem to react nonspecifically if we limit our ideas of specificity in signalling to molecular 'handshakes' that depend on complementarity, as in the case of insulin binding to its receptor. Such handshakes are well suited to the transmission of a signal along a discrete pathway. By contrast, reactions of ROS with specific atoms that are present in many macromolecules might transmit signals to multiple pathways at once. Depending on the origin and level of ROS, this might occur in discrete subcellular locations or across a large proportion of the cell. ROS that are produced by a local source in small enough amounts to be confined to a restricted subcellular location can function as a rheostat for discrete signalling pathways in that location. ROS that are produced in large enough amounts to diffuse across more of the cell can function as coordinators of global signalling in the cell. After ROS have accumulated to a certain level, their activating effects might give way to inhibitory effects. As a result, the diverse signalling pathways that are simultaneously regulated by cellular ROS levels are associated with the metabolic state of the cell 30 . Consistent with the idea of 'atomic specificity' , one of the atoms with which ROS most often reversibly reacts in cell signalling -sulphur -is one of the least abundant atoms in biological macromolecules. Even then, ROS do not react with all sulphur atoms, but mostly with a subset of sulphur atoms in the side chains of cysteine or methionine residues in peptides or proteins. Many of the most ROS-reactive cysteines in proteins are located in environments that are conducive to the participation of the thiolate in active site chemistry. The reactivity of specific cysteinyl thiols is partly influenced by neighbouring amino acid side chains that confer an acidic dissociation constant (low pKa), but additional factors are also involved that remain to be identified 31 . Much remains to be learned about this important form of intracellular signalling 32 . Molecular targets: proteins. A partial list of proteins that have been reported to be physiologically regulated by ROS includes tyrosine and serine/threonine phosphatases, such as phosphatase and tensin homologue (PTEN) 33 ; tyrosine and serine/threonine kinases, such as epidermal growth factor receptor 34 , protein kinase B 35 , ataxia-telangiectasia mutated (ATM) kinase 36 , calmodulin-dependent kinase II 37 and protein kinase G-Iα 38 ; zinc-finger proteins 39 ; other transcription factors, including those of the forkhead box O (FOXO) family 40 ; histone deacetylases 41 ; signal-regulating binding proteins, such as heatshock proteins 41 ; caspases 41 ; metalloproteinases 42 ; protease inhibitors, such as α1-antitrypsin 43 , α2-macroglobulin 44 and secretory leukocyte protease inhibitor 45 ; metabolic enzymes; prolyl hydroxylase 46 and glucose uptake regulator 47 , which both depend on α-ketoglutarate as a co factor; GTP cyclohydrolase 48 ; guanylyl cyclase 49 ; and ion channels, such as the ryanodine receptor 50 . An important role of ROS in signal transduction is to transiently oxidize the cysteine sulphydryl that contributes to the active site of most phosphatases. The phosphorylation that follows the binding of a ligand to its receptor is usually attributed to the activation of a kinase, but can also be the result of a burst of ROS formation and the transient inactivation of cognate phosphatases. Proteome-wide assessment has shown that ROS regulation of phosphatases, and hence of phosphorylation, is widespread 51 . In other proteins, ROS sensing by cysteine residues can provide feedback control to regulate the levels of ROS. For example, the intermolecular oxidation of conserved cysteines in the transcription factor FOXO4 allows for the binding of this protein to the p300/CBP acetylase, which leads to lysine acetylation of FOXO4. Such a phenomenon might be related to the ROSdependent transcriptional induction of manganese superoxide dismutase, catalase, peroxiredoxin and sulphiredoxin, and to the reduction in levels of ROS 40, 52 . Similarly, oxidation of important cysteine residues in ATM kinase promotes glucose flux through the pentose phosphate shunt, increasing the levels of NADPH. NADPH is the physiological reductant for oxidized glutathione and thioredoxin, and thus, the ultimate reductant for many ROS-catabolizing enzymes, such as glutathione reductase, peroxiredoxins and methionine sulphoxide reductases 53 . Regulation of ROS seems to be important for the functions of ATM in haematopoiesis 54 and neoangiogenesis 55 . A main function of ROS is their contribution to the activation of transcription by several mechanisms. For example, the bacterial transcription factor SoxR is activated by the superoxide anion, which interacts with the iron-sulphur redox centre of SoxR, whereas another transcription factor, OxyR, is activated by H 2 O 2 , which oxidizes the cysteinyl thiol of OxyR. Both events lead to the expression of antioxidant enzymes 56 . Moreover, ROS-facilitated protein phosphorylation can lead to the kinase-mediated activation of a transcription factor such as JUN, or to the translocation to the nucleus of a cytosolic transcription factor such as nuclear factor-κB (NF-κB) following the kinase-triggered ubiquitylation and subsequent degradation of its inhibitor (FIG. 3) .
ROS can also promote transcription by increasing the accumulation of transcription factors via inhibition of their degradation. For example, increased production of ROS by hypoxic mitochondria (FIG. 4) has an important role in preventing the degradation of hypoxia-inducible factor 1α (HIF1α), which is the main transcription factor that cells use to adapt to the hypoxic state [57] [58] [59] . In turn, HIF1α mediates hypoxic transition to glycolytic metabolism, reducing electron flow through mitochondria and reducing the associated production of ROS. Thus, the generation of reactive oxygen intermediates (ROIs; a subset of ROS) under hypoxic conditions should not be viewed as a wasteful process carried out by a poorly evolved system, but rather as an elegant network, through which the reduction in the availability of a crucial molecule triggers transcriptional adaptation.
Molecular targets: DNA. Mitochondrial ROS can promote transcription by oxidizing DNA itself, rather than by oxidizing DNA-binding regulatory proteins (FIG. 5a) . For example, ROS that are produced by hypoxic mitochondria oxidize specific bases in the promoter of vascular endothelial growth factor (VEGF). This enhances binding of HIF1α to the VEGF promoter 60 . Evidence for the physiological relevance of this response comes from the observation in pulmonary artery endothelial cells that hypoxia triggers dynein-dependent movement of mitochondria along microtubules so that the mitochondria cluster around the nucleus. As a result, mitochondrial-dependent ROS promote oxidative modifications of, and HIF1α binding to, the VEGF promoter 61 . Thus, ROS are physiological mediators in signalling between mitochondria and the nucleus 9 .
In another example of gene regulation through DNA oxidation (FIG. 5b) , transcriptional activation by the oestrogen receptor, the androgen receptor, the retinoic acid receptor, the thyroxin receptor and activator protein 1 all require topoisomerase IIb-mediated, site-specific DNA breaks in target gene-regulatory regions 62 . ROS are involved in the formation of these breaks. The oestrogen receptor-activated flavin-dependent lysinespecific histone demethylase 1 (LSD1; also known as KDM1A) produces H 2 O 2 (REF. 63 ). This locally produced H 2 O 2 oxidizes bases in target gene-regulatory regions, forming 8-oxoguanine. 8-oxoguanine recruits 8-oxoguanine DNA glycosylase 1 (OGG1), which causes single-stranded DNA breaks. These breaks recruit topoisomerase IIb, which bends DNA while repairing the lesion, thereby enabling the transcription initiation complex to access the targeted promoters 63 . The same process seems to be required for MYC-mediated transcription 64 . Thus, ROS arising from NOXs at the plasma, endosomal and phagolysosomal membranes, and from mitochondria in the cytosol, can influence transcription by regulating the phosphorylation of transcription factors; whereas ROS arising from perinuclear mitochondria or from a nuclear flavoenzyme can participate in transcriptional control by targeting DNA directly. This recent understanding of ROS-DNA interactions complements the long-standing recognition of the mutagenic potential of ROS.
Effects of ROS in the immune system
In the immune system, ROS are neither unique products of one subset of cells, such as phagocytes, nor do they have one action, such as to kill other cells. Instead, ROS have a physiological role in signalling that probably extends to every cell type in immunology. As with any signalling mechanism, ROS can become cytotoxic if the signal is too strong, if it lasts too long or if it arises at the wrong time or place.
ROS in innate immunity.
The first functional role ascribed to the production of ROS by mammalian cells was the killing of microorganisms by phagocytes (TIMELINE). This was confirmed by the discovery that individuals with chronic granulomatous disease (CGD), a disorder characterized by heightened susceptibility to infection, have disease-causing mutations in NOX2, the main source of ROS in polymorphonuclear leukocytes (PMNs) and mononuclear phagocytes. Activation of tumour necrosis factor receptor (TNFR) triggers reactive oxygen species (ROS) production, which enhances the phosphorylation (P) of inhibitor of NF-κB (IκB), probably through the oxidative inhibition of a phosphatase. This leads to the ubiquitylation (Ub) of IκB and its subsequent degradation by the proteasome. Nuclear factor-κB (NF-κB) is then released and translocates to the nucleus to initiate transcription. ROS production can also trigger oxidative glutathionylation of NF-κB at its redox sensitive cysteine, which reduces its DNA binding affinity 133 . Under normoxia, prolyl hydroxylases (PHs) hydroxylate hypoxia-inducible factor 1α (HIF1α), which allows it to be recognized by the E3 ligase von Hippel-Lindau tumour-suppressor protein (VHL) and promotes its degradation by the proteasome. Under hypoxia there is increased production of ROS (FIG. 4) , which inhibits prolyl hydroxylases, leading to the accumulation of HIF1α. HIF1α then translocates to the nucleus to mediate gene transcription. ROS production by NADPH oxidases (NOXs) following receptor activation by specific ligands, for example, epidermal growth factor receptor (EGFR), inhibits protein tyrosine phosphatases (PTPs), which promotes the phosphorylation of tyrosine kinases (TKs) and the subsequent signal transduction. By contrast, ataxia-telangiectasia mutated (ATM) kinase is activated directly by ROS, through disulphide bond-mediated homodimerization, which leads to the phosphorylation of heat shock protein 27 (HSP27) and the subsequent activation of glucose-6-phosphate-dehydrogenase (G6PD). The resulting increase in NADPH levels contributes to the maintenance of cellular redox homeostasis. ROS-mediated disulphide bonding can also lead to heterodimerization, as seen between forkhead box O (FOXO) transcription factors and p300/CBP acetyltransferase, which leads to the acetylation of FOXO proteins and the activation of specific gene transcription. ERK, extracellular signal-regulated kinase. Moreover, H 2 O 2 that is produced in PMNs can contribute to PMN migration by promoting the accumulation of phosphatidylinositol-3,4,5-trisphosphate at the leading edge of the plasma membrane. NOX2 that is localized at the plasma membrane generates H 2 O 2 , which transiently inactivates the phosphatase PTEN, allowing inositol polyphosphates to accumulate 33 . At the peak of a chemotactic gradient, where migrating PMNs congregate and begin to ingest bacteria, ROS levels are probably much higher and more sustained than near individual PMNs that are beginning to emigrate from the bloodstream. High ROS levels can suppress cell motility by promoting the accumulation of glutathionylated actin, which is impaired for polymerization 67 . Thus, ROS can coordinate the migration of PMNs towards the pathogens that wounding will probably introduce, and then ROS can promote the retention of the PMNs at that site.
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Consistent with the potential role of NOX2 in the migration of mammalian PMNs, NOX2-deficient PMNs failed to migrate up a chemotactic gradient in vitro or to sites of inflammation in vivo 68 . Thus, the immunodeficiency of CGD not only involves defective bacterial killing, but might also be a result of delayed PMN accumulation. Therefore, it might seem paradoxical that CGD was named for the tendency to form excessive granulomas; however, this might reflect an impaired oxidative inactivation of chemotactic factors, such as C5a, formylated peptides and LTB4 (REFS 69, 70) . This indicates that ROS might help not only to initiate but also to terminate inflammation.
As mentioned above, host-derived factors, such as IL-8 and C5a, which are induced in response to bacterial products, can trigger ROS production from leukocytes. However, bacteria can also trigger ROS production directly through diverse types of receptors on leukocytes. For example, Toll-like receptor (TLR) engagement can induce ROS production by NOX2 and by other sources that contribute to signalling. NOX2-derived ROS were shown to be required for X-box-binding protein 1 (XBP1)-mediated transcriptional responses downstream of TLR2 and TLR4 that led to control of Franciscella tularensis 71 . In macrophages, TLR1, TLR2 and TRL4 engagement recruited mitochondria to phagosomes and promoted mitochondrial H 2 O 2 production, which contributed to the control of Salmonella enterica subsp. enterica serovar Typhimurium infection in vitro. Mice expressing mitochondrial catalase had a twofold to threefold greater burden of S. Typhimurium 5 days after infection compared with wild-type mice 72 . However, it is not clear whether TLR-induced mitochondrial ROS are required for mice to clear infection.
ROS and inflammasomes.
An important question in innate immunity is how structurally diverse agonists activate the same inflammasomes. ROS seem to mediate inflammasome activation in a range of circumstances, although the molecular steps involved and the sources of ROS remain controversial. The late Jurg Tschopp and his colleagues advanced a theory based on the premise that all known activators of the NOD-, LRR-and pyrin domain-containing 3 (NLRP3) inflammasome induce ROS, which lead to the dissociation of thioredoxininteracting protein (TXNIP) from thioredoxin. They proposed that mitochondria are the source of ROS and that the association of TXNIP with NLRP3 is the basis of its activation 73 . Other work indicates that diverse 
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). If cellular O 2 is low, complex IV at the end of the METC is slow to transfer pairs of electrons to O 2 (making water), and the METC is blocked between complex III and IV, which favours the electron leak described above. The newly formed superoxide dismutates to H 2 O 2 . H 2 O 2 can inhibit HIF-PH2 and oxidatively decarboxylate its cofactor, αKG. The resulting decrease in the hydroxylation of HIF1α and its subsequent proteasomal degradation supports HIF1α accumulation. Dashed arrows indicate the reactions that are slowed in hypoxia. 
Granulomas
Histological collections of macrophages, usually surrounded by lymphocytes and sometimes fibrocytes. Some of the macrophages might seem to be 'epithelioid' or fuse to become multinucleated giant cells. Granuloma formation is a chronic inflammatory response to various infectious and non-infectious agents.
NLRP3-activating stimuli might converge to promote mitochondrial damage. Damaged mitochondria produce excess ROS, which attack the mitochondrial DNA. Oxidized mitochondrial DNA enters the cytosol, and binds to and activates NLRP3 (REF. 74 ).
Further studies might help to clarify the links between diverse NRLP3-activating stimuli, mitochondrial damage and the resulting ROS overproduction. It is possible that another source of ROS might initiate the mitochondrial damage, in effect beginning a process that then becomes self-sustaining. This might explain why knock down of the common NOX2 subunit p22phox (also known as CY24A) decreased IL-1β secretion in response to a range of inflammasome activators 75 . It remains to be explained what terminates this process that risks initiating a positive feedback loop that could be lethal for the cell. In fact, production of mature IL-1β is closely associated with apoptosis 76 .
ROS, the intestinal microbiota and enteric pathogens.
In contrast to patients with CGD, mice that are only deficient in NOX2 are not susceptible to spontaneous infections during standard husbandry, which is similar to mice that are only deficient in inducible nitric oxide synthase (NOS2; also known as iNOS). However, mice lacking both NOX2 and NOS2 succumb to spontaneous, invasive infections by their own microbiota in the form of massive abscesses filled with PMNs and monocytes 77 . It seems that the antibiotic proteins and peptides, the acidification pumps, the lysosomal hydrolases and the autophagic mechanisms of PMNs and monocytes are not effective in the infected organs in the absence of both NOX2 and NOS2. This might indicate that both ROS and RNS are required to integrate with the other mechanisms listed above. Indeed, ROS are required for antibacterial autophagy in PMNs, macrophages and some epithelial cells 78 . The partial mutual redundancy Engagement of ORs or ARs promotes the phosphorylation (P) of lysine-specific histone demethylase 1A (LSD1) by cAMP-dependent protein kinase (PKA). Active LSD1 not only demethylates histone 3 (H3) but also produces ROS, which then promote the formation of 8OG in the DNA. The altered DNA bases recruit base excision repair machinery, and the DNA breaks that are generated by 8OG DNA glycosylase 1 (OGG1) enable the activation of transcription by AR, OR and possibly also MYC.
Neddylation
A process that is analogous to ubiquitylation, in which ubiquitin-like protein NEDD8 is conjugated to a protein substrate.
of NOX2 and NOS2 obscures the full importance of ROS in controlling infection. Taken together, these data show that NOX2 and NOS2 are essential for mice to coexist with their microbiota 77 . DUOX in colonic epithelial cells also contributes to coexistence of the host with the microbiota. This enzyme produces submicrobicidal levels of ROS in response to commensal bacteria, such as Lactobacilli spp., which promote epithelial repair and suppress inflammatory responses 79 . One mechanism of suppression of inflammation by ROS involves the reversible, oxidative inactivation of a component of the neddylation pathway, which prevents the ubiquitylation and the proteasomal degradation of inhibitor-α of NF-κB (IκBα) and the activation of NF-κB 80 . By contrast, high levels of ROS that are produced during intestinal inflammation, along with high levels of RNS, contribute not only to the suppression of microbial growth but also to epithelial injury 79 . Some intestinal pathogens capitalize on inflammatory ROS production. For example, ROS can convert endogenous thiosulphate into tetrathionate, which S. Typhimurium can use as an electron acceptor 81 to achieve a growth advantage in regions of the intestinal lumen that are nearly anoxic 79 .
ROS and the regulation of lymphocyte function. ROS were discovered when phagocytosing leukocytes were found to consume large amounts of oxygen by a nonmitochondrial process (TIMELINE). B cells and T cells neither phagocytose nor show large increases in mitochondrial-independent oxygen consumption following activation. Thus, it was assumed that ROS have no role in adaptive immunity, and little notice was paid when superoxide production by the 'phagocyte oxidase' was discovered in transformed 82 and primary 83 human B cells at about one-tenth of the levels of ROS that are released by phagocytes. However, later studies showed that ROS production is functionally important in lymphocytes. Following B cell receptor (BCR) ligation, ROS transiently inactivate BCR-associated phosphatases and function synergistically with calcium transients to potentiate signal transduction 84 . Similarly, T cell receptor (TCR) engagement triggers ROS production, with superoxide and peroxide regulating pro-apoptotic and proliferative pathways, respectively 85 . NOX-derived ROS that are released outside of the plasma membrane or into the lumen of a plasma membrane-derived vesicle enter the T cell via aquaporin 3 to affect cytosolic phosphatases 86 . T cell-derived peroxide also activates NF-κB, which leads to the production of IL-2 (REF. 87 ). T cell activation also indirectly depends on ROS, in that the consumption of protons by NOX2 in the phagosomes of dendritic cells (DCs) retards phagosomal acidification, impedes the action of proteases and preserves peptides of sufficient length to be presented on MHC molecules 88 . Lymphocytes could not be cultured until Mishell and Dutton 89 discovered the trophic effect of supplementing the medium with the reducing agent 2-mercaptoethanol 89 . Using transformed lymphocytes, Nathan and Terry 90 showed that non-activated macrophages could replace the reducing agent to sustain lymphocyte growth, but that activated, ROS-producing macrophages could not 90 (TIMELINE). Subsequent work established that macrophages and DCs can respond to various stimuli, including contact with antigen-specific T cells, by secreting glutathione, which is broken down to release cysteine, an amino acid that is otherwise scarce in extracellular fluid. Cysteine uptake allows the lymphocytes to synthesize their own glutathione, to maintain redox homestasis, and to undergo antigen-specific activation and proliferation 91 . Consistent with the observation that mouse macrophages differ in their secretion of lymphocyte-trophic thiols depending on their activation state 90 , lamina propria-resident human macrophages secrete little cysteine, and neighbouring T cells are fairly glutathione-deficient and hyporeactive, whereas the lamina propria is infiltrated by innate immune cells with higher cysteine-releasing capacity during inflammatory bowel disease 92 . Moreover, regulatory T (T Reg ) cells can suppress glutathione release by DCs, thereby indirectly regulating the activation potential of other T cells 93 .
As noted above, even though ROS help to mediate T cell activation, T cell activation also partly depends on help from accessory cells to maintain T cell levels of the antioxidant glutathione. This indicates that ROS can be immunosuppressive. Indeed, ROS were the first molecules found to suppress T cell function 94 . Some T Reg cells can suppress other T cells through their release of ROS, and T Reg cells can be induced by macrophage-derived ROS 95, 96 . In keeping with these observations, T Reg cells were found to be more resistant to ROS than effector T cells; their enhanced resistance was associated with greater secretion of thioredoxin 97 . Myeloid-derived suppressor cells (MDSCs) are a heterogeneous population of immature myeloid cells that are temporarily restricted from further differentiation. MDSC numbers can increase tenfold in the blood of patients with cancer and inflammatory disorders [98] [99] [100] . During cancer progression, the recruitment of MDSCs to the tumour site can suppress immune reactivity 101 . MDSCs produce large quantities of ROS. ROS production not only underlies the immunosuppressive properties of MDSCs but it is also thought to maintain them in an undifferentiated state 99, 102 . Nitration of CD8, TCR, and CC-chemokine ligand 2 (CCL2) by MDSC-derived peroxynitrite prevents the binding of CD8 + T cells to peptide-loaded MHC class I, promotes antigen-specific tolerance and impairs cytotoxic T cell recruitment to tumours 101, 103 . MDSCs from mice lacking NOX2 demonstrated little or no ROS production and they lacked the ability to suppress T cell proliferation and the production of IFNγ 101, 103 .
ROS and tumour cells. Once ROS were discovered to be a principal mechanism by which the immune system controls pathogens, investigators asked whether ROS also contribute to the ability of activated macrophages to selectively kill tumour cells. In several mouse models ROS seemed to account for much of the antitumour activity of immunologically activated macrophages [104] [105] [106] . Killing could be greatly increased by pharmacologically inhibiting tumour cell glutathione synthesis or glutathione reductase, or by restricting dietary selenium, which is required for the function of glutathione peroxidase 107 . It was even possible to mimic activated macrophages with an artificial, particulate H 2 O 2 -generating system and to cure mice of an advanced lymphoma 108 . However, human cells proved to be about 100-fold more resistant to ROS than their mouse counterparts 109 . Moreover, cell lines derived from metastatic human tumours were found to produce ROS at high levels 110 . The phenomenon of ROS overproduction by tumour cells has been widely confirmed 111 . In some cases, excessive ROS production has been attributed to mutations in a mitochondrial gene that encodes a component of the mitochondrial electron transport chain. Introduction of those mutations into other tumour cells was sufficient to confer both enhanced ROS generation and ROS-dependent metastatic potential 112 . ROS release by tumour cells might sensitize, or even self-activate, their growth factor receptors by inhibiting the associated tyrosine phosphatases 51, 113 . Tumour cell ROS production might also help to explain how tumour cells alter their central carbon metabolism 114 -for example, towards synthesis of nucleic acid precursors 23 -and it might also contribute to immunosuppression. Moreover, the mutagenic actions of ROS that are derived from inflammatory cells can contribute to the initial stages of tumorigenesis 115 . After a tumour is established, ROS derived from radiotherapy, from chemotherapy or from the tumour cells themselves might contribute to the genomic instability of tumour cells 116 , fostering drug resistance, just as ROS production that is induced in bacteria by antibiotics can cause mutations that promote antibiotic resistance 117 . Finally, tumour cell-derived ROS can trigger the tumour stroma to produce angiogenic factors 111 . In contrast to more differentiated cancer cells, cancer stem cells exhibited lower levels of intracellular ROS, greater levels of antioxidant pathways and more efficient DNA repair responses to ionizing radiation [118] [119] [120] . Thus, the effects of ROS on tumours can range from tumour-promoting effects to tumour-destroying effects, which means that ROS-producing phagocytes are potentially dangerous cells for both the tumour and the host.
Looking ahead
Two sets of questions loom large over ROS biology: the mechanisms of ROS production and action, and the translational potential of this information in medicine.
Mechanistic mysteries. It remains unclear exactly how cytokines, TLR ligands, inflammasome agonists and lymphocyte antigen receptors trigger ROS production and how the subcellular localization, the magnitude and the duration of ROS production determine their specific functions. Systems biology has yet to integrate ROS biology fully into the 'wiring' diagrams that reflect our understanding of cellular behaviour.
These advances will partly depend on the development of tools that would help to identify ROS and their subcellular localization and to quantify them at the level of single cells and single molecular species in real time. These tools are beginning to be developed but the challenges are considerable. Not all redox couples in a cell are maintained at the same equilibrium, and it is not well understood what insulates one couple from another. Some of the older organic dyes that react with ROS to produce or suppress fluorescence lack specificity for individual ROS 121 . Newer approaches that allow for sensitive and specific measurement of ROS include small compounds 122 ; novel delivery systems, such as nanotubes 123 and peroxalate micelles 124 ; and genetically encoded redox-sensitive fluorescent proteins, such as redox-oxidation-sensitive green fluorescent proteins (roGFPs) 125 . The use of some genetically encoded biosensors is limited by their slow or irreversible response to changing redox levels. However, roGFPs that are fused with glutaredoxin can capture real-time changes in the aspect of cellular redox potential that is linked to the redox state of glutathione 126 . Another challenge is to determine the extent of oxidation of specific targets, both per single molecule and as a proportion of the molecules of a given molecular species. Quantitative redox proteomic techniques are struggling with this challenge 121 .
Medical advances. The disappointing history of efforts to prevent or to treat disease with exogenous antioxidants does not reflect the important role of ROS in pharmacology. Many drugs partly work by generating ROS, by inducing intracellular production of ROS, by sensitizing cells to ROS 107 , by diminishing the cellular production of ROS or by increasing the catabolism of ROS 111, 127, 128 . For example, many antibiotics kill bacteria partly by inducing them to make ROS. β-lactams, which target peptidoglycan synthesis in the bacterial cell wall, and aminoglycosides, which inhibit the bacterial ribosome, both create metabolic stress that results in NADH auto-oxidation and O 2
• 129, 130 . In short, a principal biochemical mechanism of host defence that evolved in the immune system over millions of years matches a major form of artificial host defence that was engineered by scientists over the past few decades. This is not a coincidence; it is a consequence of convergent evolution. Most antibiotics in clinical use are, or mimic, natural microbial products -signalling molecules that microorganisms use to communicate with each other. Apparently, similar advantages in fitness against microbial competitors supported the evolution of small, secreted, ROS-inducing molecules in bacteria and large, ROS-generating intracellular enzymes in eukaryotes. A better understanding of how antibiotics lead to ROS production as part of their mechanism of action 129 could help the urgent need to revitalize antibiotic research and discovery 131 . Some anti-infectives, such as clofazimine 151 , and anticancer agents that also have antibiotic actions, such as adriamycin 152 and bleomycin 153 , produce ROS directly. In the case of the anticancer agents, ROS production contributes both to their efficacy and to their toxicity.
Among the unanticipated anti-inflammatory actions of statins is their ability to decrease ROS production by endothelial cells. The synthetic oleanoid triterpenoids, one of the newest classes of antiinflammatory agents, partly work by binding to KEAP1 (Kelch-like ECH-associated protein 1), which releases nuclear-related factor 2 (NRF2; also known as NF2L2) to induce a panoply of endogenous antioxidant defences 132 .
Substantial medical advances could result from an increased understanding of how to foster or to inhibit ROS production, and how to monitor the effects of these interventions.
Note added in proof
Two recent reports 154, 155 demonstrated that killing of Escherichia coli by norfloxacin, ofloxacin, kanamycin or ampicillin does not involve ROS.
